ENDO2024
At ENDO2024 in Boston, USA, we presented our newest finding of ZAP-010 to improve glucose tolerance and neuronal insulin sensitivity in the hypothalamus.
PANS2024
At PANS2024 in Brazil, we were thrilled to present and share our work on the appetite suppressant and weight loss effects of ZAP-010 with researchers in North and South America.